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The EPHA2 gene is associated with cataracts linked to
chromosome 1p
Alan Shiels,1,2 Thomas M. Bennett,1 Harry L.S. Knopf,1 Giovanni Maraini,3 Anren Li,4 Xiaodong Jiao,4
J. Fielding Hejtmancik4
1Department

of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO; 2Department of
Genetics, Washington University School of Medicine, St. Louis, MO; 3Department of Ophthalmology, University of Parma, Parma,
Italy; 4Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD
Purpose: Cataracts are a clinically and genetically heterogeneous disorder affecting the ocular lens, and the leading cause
of treatable vision loss and blindness worldwide. Here we identify a novel gene linked with a rare autosomal dominant
form of childhood cataracts segregating in a four generation pedigree, and further show that this gene is likely associated
with much more common forms of age-related cataracts in a case-control cohort.
Methods: Genomic DNA was prepared from blood leukocytes, and genotyping was performed by means of single
nucleotide polymorphism (SNP) markers, and short tandem repeat (STR) markers. Linkage analyses were performed with
the GeneHunter and MLINK programs, and association analyses were performed with the Haploview and Exemplar
programs. Mutation detection was achieved by PCR amplification of exons and di-deoxy cycle-sequencing.
Results: Genome-wide linkage analysis with SNP markers, identified a likely disease-haplotype interval on chromosome
1p (rs707455-[~10 Mb]-rs477558). Linkage to chromosome 1p was confirmed using STR markers D1S2672 (LOD score
[Z]=3.56, recombination distance [θ]=0), and D1S2697 (Z=2.92, θ=0). Mutation profiling of positional-candidate genes
detected a heterozygous transversion (c.2842G>T) in exon 17 of the gene coding for Eph-receptor type-A2 (EPHA2) that
cosegregated with the disease. This missense change was predicted to result in the non-conservative substitution of a
tryptophan residue for a phylogenetically conserved glycine residue at codon 948 (p.G948W), within a conserved
cytoplasmic domain of the receptor. Candidate gene association analysis further identified SNPs in the EPHA2 region of
chromosome 1p that were suggestively associated with age-related cataracts (p=0.007 for cortical cataracts, and p=0.01
for cortical and/or nuclear cataracts).
Conclusions: These data provide the first evidence that EPHA2, which functions in the Eph-ephrin bidirectional signaling
pathway of mammalian cells, plays a vital role in maintaining lens transparency.

Light scattering opacities of the crystalline lens, or
cataracts, are a common ocular symptom of aging (>50 years),
and despite advances in their surgical treatment age-related
cataracts remain a leading cause of visual impairment,
accounting for ~40% of world blindness [1]. Rarely, cataracts
may present at birth (congenital), during infancy or during
childhood with an estimated prevalence of 1–13 cases/10,000
live births [2], and are clinically important as a cause of
impaired form vision development accounting for 5%–20%
of childhood blindness [3]. As much as 40% of early-onset
cataracts may have a genetic basis [2], either as a recognized
feature of over 50 genetic syndromes, involving other ocular
defects (e.g., microphthalmia) and systemic abnormalities
(e.g., galactokinase deficiency), or more often as an isolated
lens phenotype with autosomal dominant inheritance (Online
Mendelian Inheritance in Man; OMIM). To date, genetic

linkage studies of over 70 extended families worldwide have
mapped at least 25 independent loci for clinically diverse
forms of nonsyndromic cataracts on 18 human chromosomes
[4]. The majority of underlying mutations have been identified
in
10
crystallin
genes
(CRYAA,CRYAB,CRYBB1,CRYBB2,CRYBB3,CRYBA3/
A1,CRYBA4,CRYGC,GRYGD, and CRYGS) [5-13] and 2
connexin genes (GJA3,GJA8) [14,15], which encode the
major “refractive” proteins and gap-junction-channel proteins
of the lens, respectively. The remaining mutations have been
identified in at least 10 other functionally diverse genes
including those coding for transcription factors
(HSF4,MAF,PITX3) [16-18], an aquaporin water channel
(MIP) [19], cell-junction-like proteins (LIM2,TMEM114)
[20,21], intermediate-filament-like proteins (BFSP2,BFSP1)
[22,23], a chromatin modifying protein (CHMP4B) [24], and
a solute carrier protein (SLC16A12) [25].

Correspondence to: Dr. Alan Shiels, Department of Ophthalmology
and Visual Sciences, Campus Box 8096, Washington University
School of Medicine, 660 South Euclid Avenue, St. Louis, MO,
63110; Phone: (314) 362-1637; FAX: (314) 362-1646; email:
shiels@vision.wustl.edu

In addition to conventional linkage studies of inherited
cataracts in extended families, sibling and twin studies
indicate that genetic risk factors may account for 14%–48%
of the heritability for age-related “nuclear” cataracts [26-28],
and 24%–75% of the heritability for age-related “cortical”
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cataracts [29-31]. In contrast to inherited cataracts; however,
comparatively little is known about the underlying genetic
determinants predisposing to age-related cataracts [32].
Genes linked with inherited forms of cataracts represent likely
candidate genes for age-related cataracts; however, only the
“Osaka” variation (p.A198V) in the gene for autosomal
recessive galactokinase-deficiency and congenital cataracts
(GALK1) has so far been associated unambiguously with agerelated cataracts, and this association appears to be limited to
East Asian populations [33,34]. Here we report for the first
time that variations in the gene for Eph-receptor tyrosine
kinase-type A2 (EPHA2) on 1p36 are associated with
inherited and age-related forms of cataracts in Caucasians.
METHODS
Family participants: A white American family of Western
European origin (family Mu) was ascertained through
ophthalmic records in the Department of Ophthalmology and
Visual Sciences at Washington University School of
Medicine, St. Louis, MO. Blood samples were obtained from
18 family members including 12 affected individuals, one
unaffected individual, and five spouses. Leukocyte genomic
DNA was purified using the Gentra Puregene Blood kit
(Qiagen, Valencia, CA), and quantified by absorbance at
260nm (GeneQuant pro; GE Healthcare, Waukesha, WI).
Ethical approval for this study was obtained from the
Washington University Human Research Protection Office,
and written informed consent was provided by all participants
before enrollment in accordance with the tenets of the
Declaration of Helsinki, and Health Insurance Portability and
Accountability Act (HIPAA) regulations.
Case-control participants: A case-control cohort of unrelated
individuals aged >50 years form Northern Italy was
ascertained from the Clinical Trial of Nutritional Supplements
and Age-Related Cataract Study [35]. Genomic DNA was
purified from blood samples as described previously [34], and
lens status was evaluated by grading slit-lamp and retroillumination lens photographs according to a modification of
the Age-Related Eye Disease Study (AREDS) cataract
grading system [36]. Briefly, a clear lens was defined by the
following grades at the last available grading: nuclear
opalescence <3.0; cortical opacity <5% within the five mm
diameter (dia) circle at the center of the pupil, and <15%
outside this central five mm dia circle; posterior sub-capsular
opacity <1.0 % within the five mm dia central circle. A lens
was defined as cataractous when at least one type of opacity
was present with one or more of the following grades: nuclear
opalescence ≥4.5; cortical opacity >25% inside five mm dia
central circle and/or >25% outside five mm dia circle;
posterior sub-capsular opacity >12.5% inside five mm dia
circle. Ethical approval for this study was obtained from the
University of Parma and the National Eye Institute, and
written informed consent was provided in accordance with the
tenets of the Declaration of Helsinki.
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SNP genotyping and linkage analysis: For genome-wide
linkage analysis, genotyping was performed by means of the
HumanLinkage-12 Genotyping Beadchip and the Infinium-II
whole-genome amplification and single-base extension assay
(Illumina, San Diego CA) in the Microarray Core Facility at
Washington University Genome Center. Parametric
multipoint linkage analysis performed with GeneHunter
version 2.1r5 from the easyLINKAGE Plus version 5.08
package [37]. SNP marker allele frequencies used for linkage
analysis were those calculated for Caucasians by the HapMap
project. A gene frequency of 0.001 and a penetrance of 100%
were assumed for the disease locus. Computation was
performed with GeneHunter in sets of 100 markers.
STR genotyping and linkage analysis: STR markers from the
National Center for Biotechnology Information (NCBI)
combined Généthon, Marshfield, and deCODE genetic
linkage maps were genotyped by means of a 4200 DNA
analyzer running Gene ImagIR software (Li-Cor, Lincoln,
NE) as described previously [38]. Pedigree and haplotype data
were managed using Cyrillic (v.2.1) software (FamilyGenetix
Ltd., Reading, UK), and two-point LOD scores (Z) calculated
using the MLINK sub-program from the LINKAGE (5.1)
package of programs [39]. Marker allele frequencies were
assumed to be equal, and a gene frequency of 0.0001 with a
penetrance of 100% were assumed for the disease locus.
Mutation analysis: The genomic sequence for EPHA2 was
obtained from the Ensembl human genome browser, and
gene-specific M13-tailed PCR primers (Table 1) were
selected from the NCBI re-sequencing amplicon (RSA) probe
database. Genomic DNA (2.5 ng/ul, 20 ul reactions), was
amplified (35–40 cycles) in a GeneAmp 9700 thermal cycler
using AmpliTaq polymerase (Applied Biosystems, Foster
City, CA) and gene-specific primers (10 pmol). Resulting
PCR amplicons (~250–650 bp) were either enzyme-purified
with ExoSAP-IT (USB Corporation, Cleveland, OH) or gelpurified with the QIAquick gel-extraction kit (Qiagen).
Purified amplicons were direct cycle-sequenced in both
directions with BigDye Terminator Ready Reaction Mix
(version 3.1) containing M13 forward or reverse sequencing
primers then ethanol precipitated and detected by capillary
electrophoresis on a 3130xl Genetic Analyzer running
Sequence Analysis (version 5.2) software (Applied
Biosystems), and Chromas (version 2.23) software
(Technelysium, Tewantin, Queensland, Australia). For allelespecific PCR analysis, exon-17 was amplified with three
primers (Ex17R1, Ex17SF, and T-alleleF; Table 1), and
resulting amplicons were visualized at 302 nm following
electrophoresis in 3% agarose-gels stained with GelRed
(Biotium, Hayward, CA).
SNP association analysis: For association studies, tagging
SNPs covering the EPHA2 region were selected from the
HapMap database using the Haploview program [40]. SNPs
were genotyped by a combination of TaqMan melt-curve

2043

Molecular Vision 2008; 14:2042-2055 <http://www.molvis.org/molvis/v14/a241>

© 2008 Molecular Vision

TABLE 1. PCR PRIMERS FOR MUTATION-PROFILING OF EPHA2.
Primer
Ex1F
Ex1R
Ex2F
Ex2R
Ex3F1
Ex3R1
Ex3F2
Ex3R2
Ex4F
Ex4R
Ex5F
Ex5R
Ex6F
Ex6R
Ex7F
Ex7R
Ex8F
Ex8R
Ex9/10F
Ex9/10R
Ex10/11F
Ex10/11R
Ex12F
Ex12R
Ex13F
Ex13R
Ex14F
Ex14R
Ex15F
Ex15R
Ex16F
Ex16R
Ex17F1
Ex17R1
Ex17F2
Ex17R2
Ex17F3
Ex17R3
T-alleleF
Ex17SF

Location
Intron-1
5′-upstream
Intron-2
Intron-1
Exon-3
Intron-2
Intron-3
Exon-3
Exon-5
Intron-3
Intron-5
Exon-4
Intron-6
Intron-5
Intron-7
Intron-6
Intron-8
Intron-7
Intron-10
Intron-8
Intron-11
Intron-9
Exon-13
Intron-11
Exon-14
Exon-12
Intron-14
Exon-13
Intron-15
Intron-14
Intron-16
Intron-15
Exon-17
Intron-16
Exon-17
Exon-17
3′-downstream
Exon-17
Exon-17
Exon-17

Strand
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Sense
Antisense
Antisense

Sequence (5′-3′)
gcgaccaagctgaaaccgcttatt
ggcatgaatgaacaggagtcggtt
cgtaccttcccacgcccatc
ccagcctgctgtgtgccttc
ACGGCATGGTCCACACAGGT
ccaggcacctgcccacacta
aaggaaactgatgtctgggaagga
CCAGAAGCGCCTGTTCACCA
CAGACTCGGGCCAGCACTGT
ttcctgggtgcccggtacat
gacactgtgcctttaaccacttgctc
GCTTCTTCCGGGCACCTCAG
ctctgctgtgctgccttggg
tgcctgctcgtaggcagctt
ccgccggtgaccgagaaag
ggcgtccttggaagaggcag
gattcctgcctgcgtgtcca
tggagccttcccaagtgcaa
accaccgctgcctcctca
tgggccgcattctgagcac
cctctccacccagtgtgggc
cccacagcctggtccaagtc
TGGTGGTGTAGGTGGCCTCG
tacctctgcccactcctccg
CGTCGCTGGCAGAGGTGAAC
CCCTGGACAAGTTCCTTCGGg
aactgtcctctgcccagccc
CGAGGCCACCTACACCACCA
ctgggccatcgtgtccagtc
gggcagctctgaaggttggg
tggcggagttctgcccttct
gactgggcttccctgttgcc
agggaccgctttgggtctca
ctctccctctctccctcccg
ccctgccacacacacacattc
agtggcctccctgctgtgc
gctcccagggttaagtgacgtg
gcagactgtgaacttgactgggtga
GCCGGGCAGCCGCACCCA
ggaggccactctgtttcttcaagt

Gene specific primers used for amplification and sequencing of exons 1–17 and flanking intron regions of EPHA2 on
chromosome 1p. Coding and noncoding sequence are shown in uppercase and lowercase, respectively. Antisense primers were
5′-tailed with the M13-forward universal sequence (5′-tgtaaaacgacggccagt), and sense primers were 5′-tailed with the M13reverse universal sequence (5′-caggaaacagctatgacc). The allele-specific primer (T-alleleF) was used to detect the heterozygous
c.2842G>T transversion in exon-17 as shown in Figure 3.

assays “on-demand” (Applied Biosystems), SNaPshot singlebase extension assays (Applied Biosystems), and direct
BigDye Terminator cycle-sequencing (Applied Biosystems).
TaqMan assays were run on a 7900 HT real-time PCR system
(Applied Biosystems). SNaPshot assays and di-deoxy cyclesequencing were performed on a 3130 DNA analyzer

(Applied Biosystems), and sequence analysis was performed
with the Mutation Surveyor program (Soft Genetics, State
College, PA).
Statistical analyses: Tagging SNPs and haplotype blocks
were identified using the Haploview program [40], and
association statistics including χ2, trend p values, and odds
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ratios were calculated using the Exemplar program version
4.04 (Sapio Sciences, York, PA). Hardy–Weinberg
equilibrium was assessed using a χ2 test implemented in the
Exemplar program.
RESULTS
Linkage studies: We investigated a four generation white
family from the United States (family Mu) segregating
“posterior polar” cataracts in the absence of systemic
abnormalities (Figure 1A). Autosomal dominant inheritance
was supported by father-to-son transmission in the absence of
gender bias or skipping of generations. Ophthalmic records
indicated that the cataracts usually presented in both eyes as
disc-shaped posterior sub-capsular opacities with evidence of
posterior lenticonus (Figure 1B). In three affected individuals,
opacification progressed to affect the central (nucleus) and
anterior polar regions of the lens (IV:5, IV:6, IV:7; Figure 1A).
In addition to cataracts, one affected individual had monocular
amblyopia (III:8), and two others developed strabismus
requiring corrective surgery (IV:1, IV:5). The age-atdiagnosis varied from birth to15 years, and the age-at-surgery
ranged from 0 to 44 years. Post-surgical corrected visual
acuity varied from 20/20 to 20/70 in the better eye.

© 2008 Molecular Vision

Mutation analysis: The SNP and STR intervals contained 211
and 219 positional-candidate genes, respectively, none of
which were obvious functional candidates for cataracts in
family Mu (NCBI Map Viewer). We prioritized genes for
mutation analysis of exons and intron boundaries (splicesites) primarily based on evidence of expression or function
in the eye, from the NCBI UniGene expressed sequence tag
(EST) database, and the NEIBank bioinformatics resource for
vision research [41]. Re-sequencing analysis of individuals II:
1, III:8, and III:9 from the Mu pedigree (Figure 1A) excluded
the presence of coding or splice-site mutations in several
genes including ENO1 (GeneID: 2023), which according to
NEIBank is abundantly expressed in the human lens.
However, re-sequencing of a 17-exon gene symbolized
EPHA2 (GeneID: 1969), which is also expressed in human
lens (NEIBank), identified a heterozygous c.2842G>T

For genome-wide linkage analysis, the 12 affected
individuals in family Mu were genotyped by means of the
HumanLinkage-12 Panel (Illumina), which comprises 6090
SNP markers uniformly spaced at an average genetic distance
of 0.58 cM. Parametric multipoint analysis performed with
GeneHunter (v2.1r5) detected significant evidence of linkage
(Figure 2) on chromosome 1p (pLOD 3.3), and weak evidence
of linkage on chromosome 17p (pLOD 1.8). Haplotype
reconstruction further identified a common disease interval on
1p36 (rs707455-[~10Mb]-rs477558) that cosegregated with
the disease in all 12 affected individuals (Table 2).
To validate the authentic SNP interval from the genomewide linkage scan, all 18 family members were genotyped
with STR markers. We first excluded false-positive linkage to
the SNP interval on 17p using markers D17S1852 (Z=-3.75,
θ=0) and D17S921 (Z=-∞, θ=0, data not shown).
Subsequently, we obtained confirmatory evidence of linkage
on 1p (Table 3) for markers D1S2672 (Z=3.56, θ=0),
D1S2697 (Z=2.92, θ=0), and D1S436 (Z=2.84, θ=0).
Haplotype analysis detected four recombinant individuals
within the Mu pedigree (Figure 1A). An affected female (III:
8), her affected son (IV:5), and two affected daughters (IV:6,
IV:7) were obligate recombinants distal to the centromere at
D1S214. In addition, one of the affected daughters (IV:6) was
recombinant proximal to the centromere at D1S2644.
However, no further recombinant individuals were detected
at five other intervening STR markers, consistent with the
cataract locus residing in the physical interval, D1S214-(~12
Mb)-D1S2644 (Figure 1C), which was coincident with the
SNP interval on 1p.
2045

TABLE 2. SNP DISEASE HAPLOTYPE FOR THE CATARACT-LINKED INTERVAL ON CHROMOSOME 1P.

SNP
rs707455 *
rs8627
rs1473420
rs916380
rs630075
rs6677649
rs2119508
rs2379107
rs7528979
rs6541085
rs912962
rs649101
rs2506887
rs481453
rs488834
rs7555879
rs2273348
rs4846012
rs2817594
rs3818157
rs235256
rs761162
rs1416633
rs7531416
rs3927648
rs1883661
rs4357518
rs3845596
rs7515649
rs488595
rs1007150
rs761423
rs1005753
rs3766306
rs1578215
rs477558**

Disease allele
C
A
A
A
T
A
G
A
C
A
T
T
A
T
T
G
C
G
A
G
C
A
C
A
A
A
A
T
C
G
T
G
A
T
G
G

Distance from 1-ptel
Mb
cM
7.75
13.68
8.34
14.21
8.54
14.48
9.26
15.43
9.29
15.47
9.67
16.64
9.78
16.66
9.83
16.67
10.02
16.70
10.21
16.73
10.27
16.74
10.41
16.77
10.51
16.78
10.60
16.99
10.69
17.33
10.81
17.76
11.00
18.43
11.48
20.07
11.54
20.24
11.95
21.26
12.22
21.31
14.24
24.73
14.36
24.96
14.62
25.58
14.74
25.86
14.88
26.20
14.95
26.46
15.06
26.91
15.31
27.49
15.56
27.95
16.49
29.61
17.17
30.83
17.32
31.08
17.84
32.02
17.99
32.31
18.09
32.53

The disease associated allele is shown for each SNP in the
cataract interval, which spans ~10 megabases (Mb) or ~19
centi-Morgans (cM). The asterisk denotes critical
recombinant individual III:8 in family Mu (Figure 1A) with
genotype T/T at rs707455. The double asterisk denotes critical
recombinant individual IV:6 (Figure 1A) with genotype A/A
at rs477558.
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Figure 1. Autosomal dominant posterior polar cataracts in a four generation white American pedigree (family Mu). A: Pedigree and haplotype
analysis showing segregation of seven STR markers on chromosome 1p listed in descending order from the telomere. Squares and circles
denote males and females, respectively. Filled symbols and bars denote affected status and haplotypes, respectively. B: Slit-lamp image of
left lens from affected female IV:6 (age 12 years) showing posterior sub-capsular opacity. C: Ideogram of chromosome 1p36, comparing the
cytogenetic and physical locations of STR markers defining the posterior polar cataract locus in this study (red) with those defining 3 other
loci (black) for autosomal dominant cataracts (CCV, CTPP1 and Total) [45-47], and a locus (blue) for age-related cortical cataracts [44]. M,
mega-base pairs.

transversion in exon-17 that was not present in wild type
(Figure 3B). This single nucleotide change did not result in
the gain or loss of a convenient restriction site, therefore we
designed allele-specific (G/T) PCR analysis to confirm that
the mutant “T” allele cosegregated with affected but not
unaffected members of family Mu (Figure 3C). Furthermore,
when we tested the c.2842G>T transversion as a bi-allelic
marker, with a notional allelic frequency of 1%, in a two-point
LOD score analysis of the cataract locus (Table 3) we obtained
further compelling evidence of linkage (Z=3.61, θ=0). In
addition, we confirmed that the c.2842G>T transversion was
not listed in the NCBI SNP database (dbSNP), and excluded
it as a SNP in a panel of 192 normal unrelated individuals (i.e.,
384 chromosomes) using the allele-specific PCR analysis
described in Figure 3C (data not shown). While it is possible
that an undetected mutation lay elsewhere within the disease-

haplotype interval, our genotype data strongly suggested that
the c.2842G>T transversion in exon 17 of EPHA2 represented
a causative mutation rather than a benign SNP in linkage
disequilibrium with the cataract phenotype.
The c.2842G>T transversion identified above occurred at
the first base of codon 948 (GGG >TGG), and was predicted
to result in the missense substitution of glycine to tryptophan
(p.G948W) at the level of translation (Figure 4), placing it in
the cytoplasmic sterile-α-motif (SAM) domain of EPHA2
[42,43]. Cross-species alignment of the amino acid sequences
for EPHA2 present in the Entrez protein database, performed
by means of ClustalW multiple sequence alignment, revealed
that p.G948 is evolutionarily conserved within the bony
vertebrates (Figure 4B). Moreover, the predicted p.G948W
substitution represented a nonconservative amino acid
change, with the small neutral, polar side-group (-H) of
2046
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Figure 2. Parametric multipoint LOD scores (pLOD) for linkage between the posterior polar cataract phenotype in family Mu and SNP markers
across the 22 autosomes.
TABLE 3. TWO-POINT LOD SCORES (Z) FOR LINKAGE BETWEEN THE CATARACT LOCUS IN FAMILY MU AND MARKERS ON CHROMOSOME 1P.

Marker
D1S2795
D1S214
rs707455
D1S2736
D1S489
D1S507
D1S2672
D1S436
D1S2697
EPHA2 c.
2842G>T
D1S1592
rs477558
D1S2644

Distance from 1p-tel
cM
Mb
14.20
5.50
16.40
6.88
7.75
22.90
10.54
32.30
11.97
36.20
14.90
36.20
15.15
39.90
15.74
39.90
16.29
16.32–16.36

46.20

17.94
18.09
18.90

0.00
-0.47
-0.44
-3.70
2.62
1.54
2.61
3.56
2.84
2.92
3.61

0.05
2.24
2.27
-0.64
2.38
1.41
2.38
3.25
2.59
2.66
3.30

Z at θ=
0.10
0.20
2.24
1.88
2.27
1.91
-0.37
-0.15
2.14
1.62
1.28
1.01
2.13
1.60
2.93
2.25
2.32
1.76
2.39
1.82
2.98
2.28

0.30
1.33
1.35
-0.05
1.05
0.71
1.03
1.51
1.15
1.20
1.52

0.40
0.66
0.67
-0.01
0.47
0.38
0.45
0.71
0.52
0.55
0.72

ZMax
2.27
2.30
0.00
2.62
1.54
2.61
3.56
2.84
2.92
3.61

θMax
0.07
0.08
0.05
0.00
0.00
0.00
0.00
0.00
0.00
0.00

1.26
-4.43
-∞

1.16
-0.57
-0.38

1.05
-0.33
-0.15

0.59
-0.06
0.07

0.32
-0.02
0.06

1.26
0.00
0.07

0.00
0.50
0.32

0.83
-0.14
0.03

Z values for markers on 1p listed in genetic and physical distances measured in cM and Mb, respectively, from the telomere
(1p-tel). The maximum Z values (Zmax) occurred at marker D1S2672, and at the c.2842G>T transversion in exon-17 of
EPHA2 . θ=recombination fraction.

glycine replaced by the much larger neutral, hydrophobic
side-group (-CH2-C8 H4NH) of tryptophan. Position specific
score matrix analysis (PSSM Viewer) revealed a marked
decline in value from +6 to −6 (Table 4) confirming that the
predicted p.G948W substitution occurred less frequently than
expected in proteins with the conserved SAM domain
(Conserved Domain Database [CDD] pfam00536) further
raising the likelihood of functional consequences.

Association studies: EPHA2 resides within a large interval
(D1S468-[~25.5 Mb]-D1S1622) on chromosome 1p (Figure
1C) that was previously linked with age-related cortical
cataracts in families and sib-pairs from the Beaver Dam Eye
Study [44]. To investigate the possibility that EPHA2 was
associated with age-related cataracts, we performed
candidate-gene SNP allele association studies in a casecontrol cohort from Northern Italy [34,35]. This clinically
well defined cohort was of similar European ancestry to that
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Figure 3. Mutation analysis of EPHA2
in family Mu. A: Sequence trace of the
wild type allele showing translation of
glycine (G) at codon 948 (GGG). B:
Sequence trace of the mutant allele
showing the heterozygous c.2842G>T
transversion (denoted K by the
International Union of Pure and Applied
Chemistry [IUPAC] code) that is
predicted to result in the missense
substitution of tryptophan (TGG) for
glycine at codon 948 (p.G948W). C:
Allele-specific PCR analysis using the 3
primers (Table 1) indicated by arrows in
the schematic diagram; exon-17 was
amplified as above with the sense
(anchor) primer located in intron 16
(Ex17R1), the anti-sense primer located
in the 3′-untranslated region (Ex17SF),
and the nested mutant primer specific
for the T-allele in codon 948 (T-alleleF).
Note that only affected members of
family Mu are heterozygous for the
mutant T-allele (80 bp).

of family Mu, and comprised 126 unrelated individuals with
nuclear cataracts, 119 with cortical cataracts, and 104
unrelated controls with clear lenses (Table 5). Of the cases,
28 had both nuclear and cortical cataracts, three had nuclear
and posterior sub-capsular cataracts, 10 had cortical and
posterior sub-capsular cataracts, and four had nuclear,
cortical, and posterior sub-capsular cataracts.
In an initial screen, tagging SNPs covering the EPHA2
region were genotyped using 100 samples each from
individuals with any nuclear, any cortical and no age-related
cataracts. Markers yielding p values <0.05 were further

analyzed using the entire complement of samples (Appendix
1, Figure 5). All markers were in Hardy–Weinberg
equilibrium (HWE, p>0.05) for all sample groups tested. The
highest levels of association occurred with rs7543472 (allelic
p<0.038 for cortical cataracts, and allelic p<0.021 for any age
related cataracts) and rs11260867 (allelic p<0.020 for cortical
cataracts), which lie just distal (3′) to EPHA2 (Figure 5).
However, there was no significant association with nuclear
cataracts, although results with rs7543472 were suggestive
(allelic p<0.071, Appendix 1). These findings were true
whether the analysis was for pure cortical cataracts, any
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Figure 4. Schematic diagram showing gene structure and protein domains of EPHA2. A: Exon-intron organization, mutation profile and protein
domains. Intron sizes are shown in base-pairs (bp), and codons are numbered below each exon (boxes). The approximate locations of protein
domains are indicated. SP, signal-peptide; Eph-lbd, Eph-receptor ligand binding domain; EGF-like, epithelial growth factor-like region; Fn-3,
fibronectin type-III domain; Tm-1, transmembrane domain type-1; Pkinase-Tyr, protein tyrosine kinase domain; SAM, sterile-α-motif. The
predicted p.G948W missense mutation identified in family Mu is proposed to reside in the cytoplasmic SAM domain. B: Amino acid sequence
alignment of the SAM domain from human EPHA2 and orthologs from other species, showing conservation of p.G948. Divergent aminoacids residues are shaded. The SAM domain comprises an NH2-terminal extended strand (dots), 5 α-helices (H1–5, over-lined), and a core
sub-unit (bolded). The proposed p.G948W substitution likely resides between H-4 and H-5.
TABLE 4. POSITION SPECIFIC SCORE MATRIX (PSSM) ANALYSIS OF THE PREDICTED P.G948W SUBSTITUTION IN EPHA2.
Codon
GGG
TGG

Amino
acid
G (Gly)
W (Trp)

Sidechain
-H
-CH2-C8
H4NH

Charge
0
0

Potential Hbonds
0
1

Residue
weight
57
186

Isoelectric point
6.0
5.9

Hydrophobicity
0.770
0.854

PSSM
value
6
−6

Differences in the physico-chemical properties of glycine and tryptophan are consistent with a non-conservative substitution.
The negative PSSM value indicates that tryptophan substitutes for glycine at position 948 less frequently than expected among
proteins containing the conserved SAM domain.

cortical cataracts, pure nuclear cataracts, or any nuclear
cataracts. Since association was seen between SNPs in the
EPHA2 region and cortical cataracts and suggestive results
were obtained with nuclear cataracts, the analysis was
extended to include any age-related cataracts with subsequent
increased association in SNPs from the peak region to p<0.021
with the T-allele of rs7543472, although the G-allele of
rs11260867 actually lost significance slightly (p=0.076).
Results for SNPs outside this region changed only minimally.
Because the SNPs showing the greatest association lay over
or just beyond exon 17, this region was sequenced in all
samples. The only variation occurring with a frequency
greater than 0.05 was rs3754334, a synonymous p.I958I
(C3011T) variant. This variant had minor allele frequencies
of ~34% in cataract cases and 28% in controls, and was thus
analyzed further, although the association was not as strong
as with the two distal (3′) SNPs (rs7543472 or rs11260867)
and no significant allelic p values were obtained. Allelic odds
ratios ranged from 1.5 to 1.7, for rs7543472, and 1.2–1.9 for

rs11260867, but were not significant for rs3754334. The p
values obtained were not corrected for multiple testing as
these SNPs were tested, a priori, for association with agerelated cataracts on the basis of their close proximity to a gene
linked with inherited cataracts that also maps within a known
linkage region for age-related cataracts, rather than as part of
a genome-wide scan.
Trend p values were very similar to allelic p values for
all SNPs, but the specific genotypes show greater levels of
association for all SNPs showing significant association
(Appendix 1). The most significant was p<0.007 for cortical
cataracts with rs11260867 (GG genotype), p<0.012 for
cortical cataracts and p<0.01 for any cataracts with rs7543472
(TT genotype), and p<0.019 for cortical cataracts and p<0.028
for any cataracts with rs3754334 (TT genotype). In addition,
association of nuclear cataracts with the TT genotype of
rs7543472 is marginally significant at p<0.042 and suggestive
with the TT genotype of rs3754334 at p<0.06. Genotypic odds
ratios show the greatest risk increase in individuals
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TABLE 5. AGE, GENDER AND LENS STATUS OF THE ITALIAN CASE-CONTROL COHORT OF AGE-RELATED CATARACTS.
Lens status
Any cortical
cataracts
Any nuclear
cataracts
Any cataracts
Clear lenses

Age range
57–86

Mean age (±2 SD)
75.6 (63.7–87.5)

Males (%)
57 (48)

Females (%)
62 (52)

Total
119

50–86

75.8 (63.0–88.6)

75 (60)

51 (40)

126

50–86
61–86

75.7 (63.2–88.2)
74.5 (64.6–84.5)

114 (54)
61 (59)

99 (46)
43 (41)

213
104

The cohort of unrelated individuals comprised a total of 213 age-related cataract cases and 104 clear lens controls, matched for
age and gender. Cases with both nuclear and cortical cataracts (32) were counted in both the any cortical and any nuclear groups.
Cases with any posterior sub-capsular cataracts (17) were not analyzed separately due to statistically insufficient numbers.

homozygous for the risk alleles, ranging from 1.9 to 2.1 for
rs7543472, 1.5–2.3 for rs11260867, and 2.7–3.3 for
rs3754334, depending on the type of age-related cataracts
being considered (Appendix 1).
The association of a potential risk haplotype for these
three SNPs was examined; however, the association level was
found to be essentially that of the least associated SNP. This
result was consistent with the observation that all but 4
affected individuals with the homozygous TT genotype for
rs3754334 also had a homozygous TT genotype for
rs7543472, and all but one had a homozygous GG genotype
for rs11260867. Similarly, of affected individuals with a
homozygous TT genotype for rs7543472 only a single
individual did not have a homozygous GG genotype for
rs11260867. However, because the genotype frequency of TT
for rs3754334 was only ~15% it did not show strong linkage
disequilibrium with rs11260867 (D´=0.018) or rs7543472 (D
´=0.022). In contrast, rs11260867 and rs7543472, for which
the risk genotypes have frequencies of ~80% and ~73%
respectively,
showed
strong linkage disequilibrium
(D´=0.896).
DISCUSSION
In this study, we have mapped an interval on human
chromosome 1p36 for autosomal dominant posterior polar
cataracts, and identified an underlying missense mutation
(p.G948W) in the gene coding for EPHA2, which has not
previously been associated with eye disease. Our disease
interval maps in close proximity to autosomal dominant loci
for the Volkman congenital cataract (CCV) in a Danish family
[45], posterior polar cataract (CCTP1) in a British family
[46], and total congenital cataract in a Tasmanian family
[47], raising the possibility of allelism (Figure 1C). In
addition, EPHA2 resides within a large interval (D1S468[~25.5 Mb]-D1S1622) on chromosome 1p (Figure 1C) that
was previously linked with age-related cortical cataracts in
families and sib-pairs from Beaver Dam, Wisconsin [44].
Here, we further demonstrate that variations in the EPHA2
region are associated with age-related cortical cataracts

(p=0.007), and age-related cataracts overall (p=0.01) in an
Italian population.
EPHA2 encodes a 976 amino acid, type-1 transmembrane
protein (~108 kDa) with extracellular NH2-terminal and
cytoplasmic COOH-terminal halves (Figure 4B) [42]. The
extracellular region comprises a conserved Eph-ligand
binding domain followed by a cysteine-rich EGF-like domain,
and two fibronectin type-III repeats, whereas, the cytoplasmic
region contains a conserved tyrosine kinase domain, and a
sterile-α-motif (SAM) domain [42]. The proposed p.G948W
missense substitution, cosegregating with cataracts in family
Mu, was predicted to reside in the cytoplasmic SAM domain
of EPHA2. The evolutionarily conserved ~70 amino acid
SAM domain has a compact helical structure that is believed
to facilitate protein–protein interactions [43], raising the
possibility that the predicted p.G948W substitution may
interfere with Eph-receptor oligomerization and clustering
into higher-order complexes essential for physiologic
signaling [42].
In contrast to the heterozygous genotype and dominant
phenotype linked with the p.G948W mutation in EPHA2, the
SNPs in the EPHA2 region most associated with age-related
cataracts displayed the highest odds ratios when homozygous
for the risk allele, consistent with recessive effects.
Furthermore, the p.G948W mutation was linked with
posterior polar cataracts, which most resemble age-related
posterior sub-capsular cataracts, whereas, EPHA2 SNPs were
associated with much more prevalent forms of age-related
cataracts, in decreasing order of significance; cortical
opacities > any opacities > nuclear opacities. While it is
problematic to compare inherited and age-related forms of
cataracts, it is noteworthy that some of the affected members
of family Mu also developed nuclear and anterior polar
opacities. These observations raise the possibility that EPHA2
variants may contribute to a common pathogenic mechanism
resulting in different cataract phenotypes. The existence of
any such mechanism remains to be determined; however, it is
interesting that the two SNPs in the EPHA2 region most
associated with age-related cataracts (rs7543472 and
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Figure 5. Graphical presentation of
association between SNPs in the
EPHA2 region of chromosome 1p with
age-related cataracts in the Italian casecontrol cohort. The upper panel shows a
plot of -log p-values (y-axis) from
association analyses of 21 SNPs across
the EPHA2 region. Blue diamonds
denote -log p values for pure cortical
cataracts; red squares, any cortical
cataracts; green triangles, pure nuclear
cataracts; purple x, any nuclear
cataracts; and light blue asterisks, any
cataracts. The x-axis shows the relative
physical location of each SNP measured
in mega-base-pairs. The lower panel
shows a pairwise linkage disequilibrium
(D´) Haploview plot for SNPs in the
EPHA2 region. The strength of linkage
disequilibrium (LD) is color-coded; red
indicates strong LD with SNPs showing
high correlation, and blue indicates low
LD and high recombination. The
relative positions of EPHA2 and the
adjacent FAM131C are indicated with
haplotype blocks for the European
population (CEU) from the HapMap
project
(SNPbrowser,
Applied
Biosystems).

rs11260867) lie outside the coding region near the 3′-end of
the gene, which has been shown to harbor highly conserved
translational control sequences that are believed to facilitate
an RNA-based post-transcriptional mechanism for localized
regulation of gene expression within cells [48,49].
EPHA2 is a member of the largest sub-family of receptor
tyrosine kinases, which are divided into 2 classes; the Asubclass comprising 10 receptor genes (EPHA1–10) and the
B-sub-class with 6 receptor genes (EPHB1–6) [50,51]. Eph
receptors interact with their cognate membrane-anchored
ligands, referred to as ephrins (EFNA1–6,EFNB1–3), at cell-

cell contact sites to activate bidirectional signaling pathways
effecting diverse physiologic processes including; cell
adhesion, repulsion, morphology, and migration [50,51].
Intriguingly, EPHA2 has been implicated in tumor
angiogenesis and neurite outgrowth; however, little is known
about its role in the development and homeostasis of the
avascular, noninnervated lens. Recently, however, it has been
reported that mice lacking ephrin-A5, a ligand of Epha2,
develop cataracts as a result of impaired lens fiber cell
adhesion [52]. Further characterization of Eph-ephrin
signaling pathways in the lens should provide insight into the
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pathogenetic mechanisms linking EPHA2 dysfunction with
cataractogenesis.
In conclusion, our data have associated EPHA2 with both
inherited and age-related cataracts, and suggest that
dysfunction of a member of the EphA-receptor tyrosine kinase
sub-family triggers loss of lens transparency.
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Appendix 1. Association results for SNPs in the EPHA2 region with agerelated cataracts.
Calculated significance values (p=< 0.05) show most
association between rs11260867 and any cortical cataracts,
and between rs7543472 and any cataracts. To access the data,

click or select the words “Appendix 1.” This will initiate the
download of a compressed (pdf) archive that contains the file.
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